Li-Yuan Bai, M.D., Ph.D., is the director of Division of Hematology and Oncology, and the deputy director of Clinical Trial Center at China Medical University Hospital, Taichung, Taiwan. The interest fields of professor Bai include cancer of gastrointestinal tract, pancreas, biliary tract, gastrointestinal stromal tumor, and neuroendocrine tumor. He has participated many international clinical trials in relevant fields and is the leading principle investigator in three PI-initiated, multicenter clinical trials. Prof. Bai is also active in first-in-human and early phase clinical trials, with the engagement of 34 first-in-human or phase I trials between 2014 to 2022.

Chang-Fang Chiu, M.D., Ph.D., is currently the Director of the Cancer Center at China Medical University Hospital. He completed his training at the renowned Memorial Sloan Kettering Cancer Center in New York, USA. Dr. Chiu possesses extensive experience in the diagnosis and treatment of various malignant tumors and hematological diseases. He established a patient-centered, multidisciplinary team approach to care, which is applied to over twenty major cancer types. He also built a comprehensive hematopoietic stem cell transplantation care system, dedicated to providing patients with high-quality medical care.

Dr. Su-Peng Yeh served as the Secretary-General of the Taiwanese Society of Hematopoietic Stem Cell Transplantation and has been an Executive Director of the Society since 2010. He is currently the Vice Superintendent of the Department of Internal Medicine at our hospital. Dr. Yeh specializes in hematopoietic stem cell (bone marrow) transplantation, with over 100 successful transplant cases under his belt. He is also proficient in various cancer chemotherapies and transfusion medicine. In 2006, Dr. Yeh spent a year at MD Anderson Cancer Center in the United States, focusing his research on gene therapy for breast cancer. Furthermore, Dr. Yeh actively participates in numerous clinical trials for hematologic malignancies and rare blood disorders. He is a key member of the Steering Committee for several of these trials and is the physician with the most extensive experience in CAR-T cell therapy at our hospital.

Chen-Yuan Lin, M.D., Ph.D., is a physician in the Hematology and Oncology Department at China Medical University Hospital. He specializes in treating various cancers, particularly esophageal cancer, and leads multiple clinical trials. He is responsible for teaching and mentoring physicians and pharmacists, with a research focus on the tumor immune microenvironment and personalized tumor antigens. Leveraging his experience with high-dose interleukin-2 and immune checkpoint inhibitors, Dr. Lin is dedicated to enhancing the precision of immunotherapy and developing more effective cancer treatment strategies.targeting cancer cells and ultimately achieving more precise treatment outcomes.

Dr. Tzu-Ting Chen graduated from China Medical University School of Medicine and completed her residency training at China Medical University Hospital. She has served as an attending physician in the Division of Hematology and Oncology since 2014, and as the Director of Blood Bank since 2021. She specializes in hematologic malignancy treatment and hematopoietic stem cell transplantation, and is a member of the Taiwan Society of Internal Medicine, Chinese Society of Hematology, Oncology, and Blood and Marrow Transplantation.

Dr. Ming-Yu Lien, an attending physician at China Medical University Hospital's Hema-Oncology Department, is a Ph.D. holder and associate professor specializing in head and neck, nasopharyngeal, and esophageal cancers. As Vice Secretary-General of the Taiwan Head and Neck Society in 2024, he frequently speaks at major conferences and leads numerous clinical trials, highlighting his leadership in academia and clinical research.

Currently serving as an attending physician in the Division of Hematology and Oncology at China Medical University Hospital, with a medical degree from National Yang-Ming University. Specializes in hematologic diseases and malignancies such as leukemia, lymphoma, and multiple myeloma, with extensive experience in cancer treatment, particularly colorectal cancer and urological tumors. Formerly a research physician in hematology-oncology, dedicated to integrating clinical expertise with innovative therapies to provide personalized, high-quality care for patients.

Chi-Ching Chen, M.D., is currently the attending physician of the division of Hematology and Oncology at China Medical University Hospital. He completed his hematology and oncology training at the China Medical University Hospital, Taiwan. He is currently pursuing a Ph.D program for aging. Dr. Chen possesses extensive experience in the diagnosis and treatment of various malignant tumors and hematological diseases. He specializes in gastrointestinal cancers (esophagus, stomach, biliary tract, pancreas and colon), blood diseases, leukemia and hematopoietic stem cell transplantation. He follows a patient-centered, multi-specialty team care model and is committed to providing patients with personalized and high-quality medical care.

Dr. Yu-Min Liao specializes in the care of breast cancer, colorectal cancer and head-and-neck cancer. He completed his residency in internal medicine and fellowship in medical oncology and hematology at China Medical University Hospital and received clinical training at City of Hope cancer center US. Dr. Liao has a strong interest in improving the quality of life of cancer survivors through important lifestyle interventions. He provides delicate care for both his active treatment patients as well as those in the survivorship phase of care

Dr. Fu-Ming Cheng is currently an attending physician in the Hematology and Oncology Department at China Medical University Hospital. He graduated from the School of Medicine at China Medical University and has obtained board certifications in oncology, hematology, and bone marrow transplantation. He specializes in the diagnosis and treatment of general hematological diseases (such as anemia), lymphoma, leukemia, myeloma, bone marrow transplantation, breast cancer, kidney cancer, bladder cancer, and prostate cancer. Dr. Cheng is committed to the philosophy of patiently listening to patients' needs and designing personalized treatment plans for each patient.